End-of-day quote
Thailand S.E.
03:30:00 03/05/2024 am IST
|
5-day change
|
1st Jan Change
|
68.75
THB
|
+1.48%
|
|
+1.10%
|
+22.77%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
16,350
|
12,750
|
11,775
|
13,725
|
14,700
|
18,000
|
Enterprise Value (EV)
1 |
15,323
|
9,538
|
7,181
|
9,080
|
9,885
|
13,003
|
P/E ratio
|
7.17
x
|
4.93
x
|
4.92
x
|
13.2
x
|
3.43
x
|
4.45
x
|
Yield
|
1.83%
|
2.59%
|
3.06%
|
1.75%
|
3.37%
|
2.33%
|
Capitalization / Revenue
|
2.23
x
|
1.49
x
|
1.57
x
|
2.67
x
|
1.42
x
|
1.4
x
|
EV / Revenue
|
2.09
x
|
1.11
x
|
0.96
x
|
1.77
x
|
0.96
x
|
1.01
x
|
EV / EBITDA
|
8.12
x
|
5
x
|
4.21
x
|
7.52
x
|
4.84
x
|
8.56
x
|
EV / FCF
|
13.1
x
|
10.9
x
|
5.36
x
|
30.3
x
|
81.3
x
|
30.5
x
|
FCF Yield
|
7.61%
|
9.16%
|
18.7%
|
3.3%
|
1.23%
|
3.28%
|
Price to Book
|
1
x
|
0.69
x
|
0.59
x
|
0.66
x
|
0.59
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
3,00,000
|
3,00,000
|
3,00,000
|
3,00,000
|
3,00,000
|
3,00,000
|
Reference price
2 |
54.50
|
42.50
|
39.25
|
45.75
|
49.00
|
60.00
|
Announcement Date
|
28/05/18
|
27/05/19
|
29/05/20
|
25/05/21
|
27/05/22
|
29/05/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,328
|
8,555
|
7,499
|
5,139
|
10,337
|
12,893
|
EBITDA
1 |
1,887
|
1,909
|
1,706
|
1,208
|
2,041
|
1,518
|
EBIT
1 |
1,697
|
1,695
|
1,469
|
997.1
|
1,861
|
1,336
|
Operating Margin
|
23.16%
|
19.81%
|
19.59%
|
19.4%
|
18%
|
10.36%
|
Earnings before Tax (EBT)
1 |
2,505
|
3,034
|
2,849
|
1,211
|
4,859
|
4,563
|
Net income
1 |
2,282
|
2,585
|
2,394
|
1,036
|
4,287
|
4,049
|
Net margin
|
31.14%
|
30.21%
|
31.93%
|
20.17%
|
41.47%
|
31.4%
|
EPS
2 |
7.606
|
8.616
|
7.981
|
3.455
|
14.29
|
13.50
|
Free Cash Flow
1 |
1,167
|
874.1
|
1,340
|
299.6
|
121.6
|
426.3
|
FCF margin
|
15.92%
|
10.22%
|
17.87%
|
5.83%
|
1.18%
|
3.31%
|
FCF Conversion (EBITDA)
|
61.8%
|
45.79%
|
78.56%
|
24.81%
|
5.96%
|
28.08%
|
FCF Conversion (Net income)
|
51.12%
|
33.82%
|
55.99%
|
28.91%
|
2.84%
|
10.53%
|
Dividend per Share
2 |
1.000
|
1.100
|
1.200
|
0.8000
|
1.650
|
1.400
|
Announcement Date
|
28/05/18
|
27/05/19
|
29/05/20
|
25/05/21
|
27/05/22
|
29/05/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,027
|
3,212
|
4,594
|
4,645
|
4,815
|
4,997
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,167
|
874
|
1,340
|
300
|
122
|
426
|
ROE (net income / shareholders' equity)
|
14.9%
|
14.9%
|
12.5%
|
5.07%
|
18.7%
|
15.2%
|
ROA (Net income/ Total Assets)
|
5.7%
|
5.59%
|
4.44%
|
2.84%
|
4.63%
|
2.84%
|
Assets
1 |
40,023
|
46,252
|
53,918
|
36,498
|
92,639
|
1,42,590
|
Book Value Per Share
2 |
54.50
|
61.20
|
67.00
|
69.40
|
83.40
|
93.80
|
Cash Flow per Share
2 |
1.270
|
5.740
|
15.30
|
15.50
|
16.00
|
16.70
|
Capex
1 |
77.3
|
296
|
195
|
27.6
|
70.9
|
191
|
Capex / Sales
|
1.05%
|
3.46%
|
2.59%
|
0.54%
|
0.69%
|
1.48%
|
Announcement Date
|
28/05/18
|
27/05/19
|
29/05/20
|
25/05/21
|
27/05/22
|
29/05/23
|
|
1st Jan change
|
Capi.
|
---|
| +22.77% | 560M | | +14.70% | 64.97B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +9.54% | 19.29B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B |
Other Specialty Chemicals
|